FDA Adverse Event
Injury
Summary report: N
FLEXTEND II
MDR report key: 1870534
·
Received October 15, 2010
Report
- Report Number
- 2124215-2010-16931
- Event Type
- Injury
- Date Received
- October 15, 2010
- Date of Event
- August 24, 2010
- Report Date
- August 24, 2010
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE PERICARDIAL EFFUSION WAS SUCCESSFULLY DRAINED AND THE PATIENT MOVED TO ICU FOR MONITORING. NO ALLEGATIONS AGAINST BSC PRODUCTS AS A CAUSE OR CONTRIBUTOR TO THE OBSERVED CLINICAL OBSERVATION. THE LEAD REMAINS IMPLANTED AND IN SERVICE.
Description of Event or Problem · 1
BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT AT THE CONCLUSION OF SYSTEM IMPLANT, THE PATIENT EXHIBITED SUSTAINED HYPOTENSION REQUIRING INOTROPIC SUPPORT. A TRANSTHORACIC ECHOCARDIOGRAPHY WAS PERFORMED, NOTING EVIDENCE OF A PERICARDIAL EFFUSION; NO HEMODYNAMIC COLLAPSE OBSERVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | FLEXTEND II | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4097 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |